I am a healthcare professional

Notice


Welcome to MEDICALLY. This website is a non-promotional international resource intended to facilitate transparent scientific exchange regarding developments in medical research and disease management. It is intended for healthcare professionals outside the United Kingdom (UK) and Australia. The content on this website may include scientific information about experimental or investigational compounds, indications and services that are not approved or valid in your jurisdiction. Registration status and prescribing information of medicinal products may differ between countries. Roche and Genentech do not support, endorse or recommend the unapproved use of any compound or service in your jurisdiction, including those discussed on this website.


Please refer to local product information for any medicinal products mentioned. Information available on this website does not constitute professional medical advice, and Roche and Genentech accept no responsibility for access to or use of the same. Healthcare professionals outside the US are required to register and log-in to access the full range of content available on this website.


By clicking on one of the healthcare professional buttons below, you acknowledge you have read and understood this message and that you are requesting access to MEDICALLY. If you are not a healthcare professional, please use the other links below to access information relevant to you.


Cookies


We use cookies on this site to enable the site to function properly and to enhance your user experience. Cookies are files stored in your browser, which most websites use to personalize your web experience. Your information will only be used to provide information that is relevant to you. It will not be used for any other purpose. If you wish to restrict or block cookies, which are set on your device, then you can do this through your browser settings.


You can find out more about cookies by browsing our Privacy Policy.

 

For healthcare professionals in Another Country browse medically.roche.com.

Not a healthcare professional? For individuals outside the US, browse Roche's patient website or roche.com. For individuals in the US, browse gene.com.

External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche at

ISBT 2023

-
Coming soon

Sign up or login to unlock the full suite of MEDICALLY features

Jun 19 / Roche
Development of a Mayaro and yellow fever virus duplex real-time RT-PCR assay for high-throughput testing
There is currently limited availability of molecular tests for arboviruses, such as yellow fever virus (YFV) and Mayaro virus (MAYV), optimized for use on high-throughput testing platforms that are commonly used in blood banks. This study reports on the development and validation of new YFV and MAYV real-time RT-PCR candidate assays for use with the cobas® omni Utility Channel on the widely used high-throughput cobas 6800 system.

Sign up or login to unlock the full suite of MEDICALLY features

Jun 19 / Roche
Comparison of two automated NAT systems for HIV, HBV, HCV
This study compared the sample process flow and operator interactions for NAT pooling and testing for HIV, HBV, and HCV on the cobas® 5800 system with those on the cobas s 201 system. The cobas® 5800 system is an automated platform for nucleic acid testing for low-volume donor screening of transfusion-transmitted pathogens. It streamlines and shortens the turnaround time from sample processing to test result compared to the cobas s 201 system. The combination of automation and workflow with the cobas 5800 system minimizes the opportunity for manual errors. It is an ideal instrument for low-volume laboratories that process donor samples in pools or by individual donation.

Sign up or login to unlock the full suite of MEDICALLY features

Jun 19 / Roche
Detection of Plasmodium in specimens from healthy asymptomatic individuals in Nigeria by cobas Malaria test
The investigational cobas® Malaria assay is a qualitative in vitro nucleic acid screening test for use on the cobas 5800/6800/8800 systems for direct detection of Plasmodium ribosomal DNA/RNA (rDNA/rRNA) in whole blood. This study compared Plasmodium detection by cobas Malaria with that by microscopy and antibody and antigen tests in healthy asymptomatic individuals from a malaria-endemic country.